resveratrol has been researched along with Ureteral Obstruction in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Guo, Y; Lu, H; Wu, C; Xiao, Y; Xie, S; Zhang, X; Zhang, Y; Zheng, S; Zhu, H | 1 |
| Bresette, W; Chen, Y; Cheng, J; Li, L; Liu, J; Liu, S; Lu, Y; Wang, C; Yuan, Y; Zhao, M; Zhou, Y | 1 |
| Han, J; Liang, J; Tian, S; Xiong, P | 1 |
| Bai, Y; Chen, B; Liang, Y; Lin, C; Lu, H; Wang, S; Wu, C; Xia, P | 1 |
| Lu, Y; Wang, D; Zhang, C; Zhou, Y | 1 |
| Breyer, MD; Davis, LS; Fan, H; Fogo, AB; Hao, CM; Harris, RC; He, W; Wang, Y; Yang, HC; You, L; Zent, R; Zhang, MZ | 1 |
6 other study(ies) available for resveratrol and Ureteral Obstruction
| Article | Year |
|---|---|
Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation-related signalling pathways.
Topics: Animals; Antioxidants; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibroblasts; Fibrosis; Kidney; Kidney Tubules; Myofibroblasts; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Ureteral Obstruction | 2019 |
Resveratrol exerts dose-dependent anti-fibrotic or pro-fibrotic effects in kidneys: A potential risk to individuals with impaired kidney function.
Topics: Animals; Cell Line; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Kidney; Kidney Tubules, Proximal; Male; Mice, Inbred C57BL; Mitochondria; Resveratrol; Sirtuin 1; Smad3 Protein; Transforming Growth Factor beta; Ureteral Obstruction | 2019 |
Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Deoxyguanosine; Fibronectins; Fibrosis; Intercellular Adhesion Molecule-1; Kidney; Kidney Glomerulus; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; Resveratrol; Smad3 Protein; Stilbenes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Ureteral Obstruction | 2014 |
Resveratrol inhibits epithelial-mesenchymal transition and renal fibrosis by antagonizing the hedgehog signaling pathway.
Topics: Animals; Cell Line; Disease Models, Animal; Epithelial-Mesenchymal Transition; Extracellular Matrix; Fibrosis; Hedgehog Proteins; Kidney; Kidney Tubules; Male; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Resveratrol; Signal Transduction; Smoothened Receptor; Stilbenes; Transforming Growth Factor beta1; Ureteral Obstruction | 2014 |
Regulation of eIF2α expression and renal interstitial fibrosis by resveratrol in rat renal tissue after unilateral ureteral obstruction.
Topics: Animals; Eukaryotic Initiation Factor-2; Fibrosis; Kidney; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes; Ureteral Obstruction | 2016 |
Sirt1 activation protects the mouse renal medulla from oxidative injury.
Topics: Animals; Apoptosis; Cells, Cultured; Cyclooxygenase 2; Fibrosis; Heterocyclic Compounds, 4 or More Rings; Kidney Medulla; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Resveratrol; Sirtuin 1; Stilbenes; Ureteral Obstruction | 2010 |